- Home
- EXK vs HCM Comparison
EXK vs HCM Comparison
Compare EXK & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXK | HCM |
|---|---|---|
| Founded | 1981 | 2000 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2004 | 2015 |
Fundamental Metrics
Financial Performance| Metric | EXK | HCM |
|---|---|---|
| Price | $11.09 | $12.26 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 4 | 1 |
| Target Price | ★ $13.94 | $13.75 |
| AVG Volume (30 Days) | ★ 8.6M | 47.5K |
| Earning Date | 05-06-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $69.59 | $20.60 |
| Revenue Next Year | $17.61 | $15.62 |
| P/E Ratio | ★ N/A | $5.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.63 | $9.77 |
| 52 Week High | $15.15 | $17.79 |
Technical Indicators
Market Signals| Indicator | EXK | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 61.93 | 54.43 |
| Support Level | $10.50 | $10.73 |
| Resistance Level | $11.31 | $12.90 |
| Average True Range (ATR) | 0.54 | 0.26 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 71.07 | 47.06 |
Price Performance
Historical ComparisonAbout EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.